JOURNAL ARTICLE

(100) Urinary and Gynecologic Adverse Events Associated with Ssri Use.

  • Published In: Journal of Sexual Medicine, 2024. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Grzyb, C; Durrani, K; Boyd Md, S 3 of 3

Abstract

This article focuses on urinary and gynecologic adverse events associated with selective serotonin reuptake inhibitors (SSRIs), based on data from the FDA Adverse Events Reporting System (FAERS). Using OpenVigil 2.1 software, the study identified statistically significant side effects beyond sexual dysfunction, including gynecologic bleeding, urinary retention, and hypersexuality, with variations observed across age groups and individual SSRIs. Citalopram showed the strongest association with sexual disorders, and urinary symptoms were most common in patients aged 0–18 and over 60. The findings provide detailed insight into SSRI-related genitourinary and reproductive side effects, which may inform clinical management and patient care.

Additional Information

  • Source:Journal of Sexual Medicine. 2024/01, p1
  • Document Type:Article
  • Subject Area:Pharmacy and Pharmacology
  • Publication Date:2024
  • ISSN:1743-6095
  • DOI:10.1093/jsxmed/qdae001.096
  • Accession Number:175495823
  • Copyright Statement:Copyright of Journal of Sexual Medicine is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.